Personas / Equipo Humano

Laia Alsina Manrique de Lara

Buscador de publicaciones

Publicaciones

  • Fliegauf M, Kinnunen M, Posadas-Cantera S, Camacho-Ordonez N, Abolhassani H, Alsina L, Atschekzei F, Bogaert DJ, Burns SO, Church JA, Dückers G, Freeman AF, Hammarström L, Hanitsch LG, Kerre T, Kobbe R, Sharapova SO, Siepermann K, Speckmann C, Steiner S, Verma N, Walter JE, Westermann-Clark E, Goldacker S, Warnatz K, Varjosalo M and Grimbacher B.

    Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50

    FRONTIERS IN IMMUNOLOGY . 13: 965326-965326. Nº de citas: 3

    [doi:10.3389/fimmu.2022.965326]

  • Ortigoza-Escobar JD, Fernández de Sevilla-Estrach M, Monfort L, Anton-Lopez J, Iglesias-Jimenez E, Rebollo M, Cristina Del prado Sanchez, Arostegui JI, Mensa-Vilaró A, Alsina L, Rodriguez-Vigil Iturrate C, Niemeyer CM, Jou-Munoz C and Català-Temprano A.

    Cytokine profile and brain biopsy in a case of childhood-onset central nervous system vasculitis in Noonan syndrome-like disorder due to a novel CBL variant

    JOURNAL OF NEUROIMMUNOLOGY . 369: 577917-577917. Nº de citas: 1

    [doi:10.1016/j.jneuroim.2022.577917]

  • Deyà-Martinez A, Rivière JG, Roxo-Junior P, Ramakers J, Bloomfield M, Guisado Hernandez P, Blanco Lobo P, Abu Jamra SR, Esteve-Solé A, Kanderova V, García-García AP, Lopez-Corbeto M, Martinez Pomar N, Martín-Nalda A, Alsina L, Neth O and Olbrich P.

    Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature

    JOURNAL OF CLINICAL IMMUNOLOGY . 42(5): 1071-1082. Nº de citas: 20

    [doi:10.1007/s10875-022-01257-x]

  • González-Granado LI, Martín-Nalda A, Alsina L, Neth O, Santamaría M and Soler-Palacín P.

    Respiratory syncytial virus infections requiring hospitalization in patients with primary immunodeficiency

    anales de pediatria . 96(6): 492-500. Nº de citas: 3

    [doi:10.1016/j.anpedi.2021.07.015]

  • Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Schmid JP, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králícková P, de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue-Salvador T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD and Grimbacher B.

    Therapeutic options for CTLA-4 insufficiency

    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY . 149(2): 736-746. Nº de citas: 60

    [doi:10.1016/j.jaci.2021.04.039]

  • Girona M, Argüello G, Esteve-Solé A, Bobillo-Perez S, Paolo-Burgos X, Bonet E, Mensa-Vilaró A, Codina-Bergadà A, Hernández-Garcia M, Jou-Munoz C, Alsina L and Jordán-García I.

    Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults

    iScience . 25(1): 103595-103595. Nº de citas: 1

    [doi:10.1016/j.isci.2021.103595]

  • Santamaria M, Neth O, Douglass JA, Krivan G, Kobbe R, Bernatowska E, Grigoriadou S, Bethune C, Chandra A, Horneff G, Borte M, Sonnenschein A, Kralickova P, Ramón SS, Langguth D, Gonzalez-Granado LI, Alsina L, Querolt M, Griffin R, Hames C, Mondou E, Price J, Sanz A and Lin J.

    A Multi-Center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

    JOURNAL OF CLINICAL IMMUNOLOGY . 42(3): 500-511. Nº de citas: 3

    [doi:10.1007/s10875-021-01181-6]

  • Alsina L, Montoro JB, Moral PM, Neth O, Pica MO, Sánchez-Ramón S, Presa M, Oyagüez I, Casado MÁ and González-Granado LI.

    Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain

    EUROPEAN JOURNAL OF HEALTH ECONOMICS . 23(3): 551-558. Nº de citas: 7

    [doi:10.1007/s10198-021-01378-x]

  • Parrado A, Rubio G, Serrano M, De la Morena-Barrio ME, Ibáñez-Micó S, Ruiz-Lafuente N, Schwartz-Albiez R, Esteve-Solé A, Alsina L, Corral J and Hernández-Caselles T.

    Dissecting the transcriptional program of phosphomannomutase 2-deficient cells: Lymphoblastoide B cell lines as a valuable model for congenital disorders of glycosylation studies

    Glycobiology . 32(2): 84-100. Nº de citas: 3

    [doi:10.1093/glycob/cwab087]

  • Keller B, Strohmeier V, Harder I, Unger S, Payne KJ, Andrieux G, Boerries M, Felixberger PT, Landry JJM, Nieters A, Rensing-Ehl A, Salzer U, Frede N, Usadel S, Elling R, Speckmann C, Hainmann I, Ralph E, Gilmour K, Wentink MWJ, van der Burg M, Kuehn HS, Rosenzweig SD, Kölsch U, von Bernuth H, Kaiser-Labusch P, Gothe F, Hambleton S, Vlagea AD, García-García AP, Alsina L, Markelj G, Avcin T, Vasconcelos J, Guedes M, Ding JY, Ku CL, Shadur B, Avery DT, Venhoff N, Thiel J, Becker H, Erazo-Borrás L, Trujillo-Vargas CM, Franco JL, Fieschi C, Okada S, Gray PE, Uzel G, Casanova JL, Fliegauf M, Grimbacher B, Eibel H, Ehl S, Voll RE, Rizzi M, Stepensky P, Benes V, Ma CS, Bossen C, Tangye SG and Warnatz K.

    The expansion of human T-bethighCD21low B cells is T cell dependent

    Science immunology . 6(64): . Nº de citas: 66

    [doi:10.1126/sciimmunol.abh0891]